APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Soliris (Eculizumab)

Eculizumab, sold under the trade name Soliris, is a medication used to treat paroxysmal nocturnal hemoglobinuria (PHN) and atypical hemolytic uremic syndrome (aHUS). It is a humanized monoclonal antibody functioning as a terminal complement inhibitor. In people with PNH, it reduces both the destruction of red blood cells and need for blood transfusion, but does not appear to affect the risk of death. Eculizumab was the first drug approved for each of its uses, and its approval was granted on the basis of small clinical trials.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Eculizumab, sold under the trade name Soliris, is a medication used to treat paroxysmal nocturnal hemoglobinuria (PHN) and atypical hemolytic uremic syndrome (aHUS). It is a humanized monoclonal antibody functioning as a terminal complement inhibitor. In people with PNH, it reduces both the destruction of red blood cells and need for blood transfusion, but does not appear to affect the risk of death. Eculizumab was the first drug approved for each of its uses, and its approval was granted on the basis of small clinical trials.

Selected research

Market Structure

Global Soliris (Eculizumab) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173895490319 December 2025177 pages

Choose your research edition.

Industry ResearchSoliris (Eculizumab) Industry Research Report 2026104 pages · $2,950 USDIndustry Growth & TrendsGlobal Soliris (Eculizumab) Industry Growth and Trends Forecast to 203263 pages · $3,450 USDMarket StructureGlobal Soliris (Eculizumab) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032177 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Soliris (Eculizumab) Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Soliris (Eculizumab) Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

Eculizumab, sold under the trade name Soliris, is a medication used to treat paroxysmal nocturnal hemoglobinuria (PHN) and atypical hemolytic uremic syndrome (aHUS). It is a humanized monoclonal antibody functioning as a terminal complement inhibitor. In people with PNH, it reduces both the destruction of red blood cells and need for blood transfusion, but does not appear to affect the risk of death. Eculizumab was the first drug approved for each of its uses, and its approval was granted on the basis of small clinical trials.

In Asia-Pacific, Japan is the largest Soliris (Eculizumab) market with about 32% market share. China is follower, accounting for about 25% market share.The key manufacturers are Alexion etc.

Report Includes

Read the full market overview

This report provides an overview of the global Soliris (Eculizumab) market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Soliris (Eculizumab) and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Soliris (Eculizumab) revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Soliris (Eculizumab) market size, projected growth trends, production technologies, key applications, and end-use industries.

Soliris (Eculizumab) Segment by Company

Alexion

Soliris (Eculizumab) Segment by Type

Plasma Exchange

Plasma Infusion

Soliris (Eculizumab) Segment by Application

PNH

aHUS

Others

Soliris (Eculizumab) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Soliris (Eculizumab) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Soliris (Eculizumab) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Soliris (Eculizumab).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Soliris (Eculizumab) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Soliris (Eculizumab) industry.

Chapter 3: Detailed analysis of Soliris (Eculizumab) companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Soliris (Eculizumab)revenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Soliris (Eculizumab) Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Plasma Exchange Table 3. Key Players of Plasma Infusion Table 4. Global Soliris (Eculizumab) Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of PNH Table 6. Key Players of aHUS Table 7. Key Players of Others Table 8. Global Soliris (Eculizumab) Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Soliris (Eculizumab) Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Soliris (Eculizumab) Market Share by Region (2021-2026) Table 11. Global Soliris (Eculizumab) Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Soliris (Eculizumab) Market Share by Region (2027-2032) Table 13. Soliris (Eculizumab) Industry Trends Table 14. Soliris (Eculizumab) Industry Drivers Table 15. Soliris (Eculizumab) Industry Opportunities and Challenges Table 16. Soliris (Eculizumab) Industry Restraints Table 17. Global Soliris (Eculizumab) Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Soliris (Eculizumab) Revenue Market Share by Company (2021-2026) Table 19. Global Soliris (Eculizumab) Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Soliris (Eculizumab) Key Company Head Office and Area Served Table 21. Global Soliris (Eculizumab) Company, Product Type & Application Table 22. Global Soliris (Eculizumab) Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Soliris (Eculizumab) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Soliris (Eculizumab) Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Soliris (Eculizumab) Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Soliris (Eculizumab) Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Soliris (Eculizumab) Revenue Market Share by Type (2021-2026) Table 29. Global Soliris (Eculizumab) Revenue Market Share by Type (2027-2032) Table 30. Global Soliris (Eculizumab) Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Soliris (Eculizumab) Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Soliris (Eculizumab) Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Soliris (Eculizumab) Revenue Market Share by Application (2021-2026) Table 34. Global Soliris (Eculizumab) Revenue Market Share by Application (2027-2032) Table 35. Alexion Company Information Table 36. Alexion Business Overview Table 37. Alexion Soliris (Eculizumab) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Alexion Soliris (Eculizumab) Product Portfolio Table 39. Alexion Recent Development Table 40. North America Soliris (Eculizumab) Market Size by Type (2021-2026) & (US$ Million) Table 41. North America Soliris (Eculizumab) Market Size by Type (2027-2032) & (US$ Million) Table 42. North America Soliris (Eculizumab) Market Size by Application (2021-2026) & (US$ Million) Table 43. North America Soliris (Eculizumab) Market Size by Application (2027-2032) & (US$ Million) Table 44. North America Soliris (Eculizumab) Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 45. North America Soliris (Eculizumab) Market Size by Country (2021-2026) Table 46. North America Soliris (Eculizumab) Market Size by Country (2027-2032) Table 47. Europe Soliris (Eculizumab) Market Size by Type (2021-2026) & (US$ Million) Table 48. Europe Soliris (Eculizumab) Market Size by Type (2027-2032) & (US$ Million) Table 49. Europe Soliris (Eculizumab) Market Size by Application (2021-2026) & (US$ Million) Table 50. Europe Soliris (Eculizumab) Market Size by Application (2027-2032) & (US$ Million) Table 51. Europe Soliris (Eculizumab) Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Europe Soliris (Eculizumab) Market Size by Country (2021-2026) Table 53. Europe Soliris (Eculizumab) Market Size by Country (2027-2032) Table 54. China Soliris (Eculizumab) Market Size by Type (2021-2026) & (US$ Million) Table 55. China Soliris (Eculizumab) Market Size by Type (2027-2032) & (US$ Million) Table 56. China Soliris (Eculizumab) Market Size by Application (2021-2026) & (US$ Million) Table 57. China Soliris (Eculizumab) Market Size by Application (2027-2032) & (US$ Million) Table 58. Asia Soliris (Eculizumab) Market Size by Type (2021-2026) & (US$ Million) Table 59. Asia Soliris (Eculizumab) Market Size by Type (2027-2032) & (US$ Million) Table 60. Asia Soliris (Eculizumab) Market Size by Application (2021-2026) & (US$ Million) Table 61. Asia Soliris (Eculizumab) Market Size by Application (2027-2032) & (US$ Million) Table 62. Asia Soliris (Eculizumab) Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 63. Asia Soliris (Eculizumab) Market Size by Country (2021-2026) Table 64. Asia Soliris (Eculizumab) Market Size by Country (2027-2032) Table 65. South America, Middle East & Africa Soliris (Eculizumab) Market Size by Type (2021-2026) & (US$ Million) Table 66. South America, Middle East & Africa Soliris (Eculizumab) Market Size by Type (2027-2032) & (US$ Million) Table 67. South America, Middle East & Africa Soliris (Eculizumab) Market Size by Application (2021-2026) & (US$ Million) Table 68. South America, Middle East & Africa Soliris (Eculizumab) Market Size by Application (2027-2032) & (US$ Million) Table 69. South America, Middle East & Africa Soliris (Eculizumab) Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 70. South America, Middle East & Africa Soliris (Eculizumab) Market Size by Country (2021-2026) Table 71. South America, Middle East & Africa Soliris (Eculizumab) Market Size by Country (2027-2032) Table 72. Research Programs/Design for This Report Table 73. Authors List of This Report Table 74. Secondary Sources Table 75. Primary Sources List of Figures Figure 1. Soliris (Eculizumab) Product Image Figure 2. Global Soliris (Eculizumab) Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Soliris (Eculizumab) Market Share by Type: 2025 VS 2032 Figure 4. Plasma Exchange Image Figure 5. Plasma Infusion Image Figure 6. Global Soliris (Eculizumab) Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global Soliris (Eculizumab) Market Share by Application: 2025 VS 2032 Figure 8. PNH Image Figure 9. aHUS Image Figure 10. Others Image Figure 11. Global Soliris (Eculizumab) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Soliris (Eculizumab) Market Size (2021-2032) & (US$ Million) Figure 13. Global Soliris (Eculizumab) Market Share by Region: 2025 VS 2032 Figure 14. Years Considered Figure 15. Global Soliris (Eculizumab) Market Share by Players in 2025 Figure 16. Global Top 5 and 10 Soliris (Eculizumab) Players Market Share by Revenue in 2025 Figure 17. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Soliris (Eculizumab) Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Soliris (Eculizumab) Revenue Market Share by Type (2021-2032) Figure 20. Global Soliris (Eculizumab) Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Soliris (Eculizumab) Revenue Market Share by Application (2021-2032) Figure 22. North America Soliris (Eculizumab) Market Size (2021-2032) & (US$ Million) Figure 23. North America Soliris (Eculizumab) Market Share by Type (2021-2032) Figure 24. North America Soliris (Eculizumab) Market Share by Application (2021-2032) Figure 25. North America Soliris (Eculizumab) Market Share by Country (2021-2032) Figure 26. United States Soliris (Eculizumab) Market Size (2021-2032) & (US$ Million) Figure 27. Canada Soliris (Eculizumab) Market Size (2021-2032) & (US$ Million) Figure 28. Mexico Soliris (Eculizumab) Market Size (2021-2032) & (US$ Million) Figure 29. Europe Soliris (Eculizumab) Market Size (2021-2032) & (US$ Million) Figure 30. Europe Soliris (Eculizumab) Market Share by Type (2021-2032) Figure 31. Europe Soliris (Eculizumab) Market Share by Application (2021-2032) Figure 32. Europe Soliris (Eculizumab) Market Share by Country (2021-2032) Figure 33. Germany Soliris (Eculizumab) Market Size (2021-2032) & (US$ Million) Figure 34. France Soliris (Eculizumab) Market Size (2021-2032) & (US$ Million) Figure 35. U.K. Soliris (Eculizumab) Market Size (2021-2032) & (US$ Million) Figure 36. Italy Soliris (Eculizumab) Market Size (2021-2032) & (US$ Million) Figure 37. Russia Soliris (Eculizumab) Market Size (2021-2032) & (US$ Million) Figure 38. Nordic Countries Soliris (Eculizumab) Market Size (2021-2032) & (US$ Million) Figure 39. China Soliris (Eculizumab) Market Size (2021-2032) & (US$ Million) Figure 40. China Soliris (Eculizumab) Market Share by Type (2021-2032) Figure 41. China Soliris (Eculizumab) Market Share by Application (2021-2032) Figure 42. Asia Soliris (Eculizumab) Market Size (2021-2032) & (US$ Million) Figure 43. Asia Soliris (Eculizumab) Market Share by Type (2021-2032) Figure 44. Asia Soliris (Eculizumab) Market Share by Application (2021-2032) Figure 45. Asia Soliris (Eculizumab) Market Share by Country (2021-2032) Figure 46. Japan Soliris (Eculizumab) Market Size (2021-2032) & (US$ Million) Figure 47. South Korea Soliris (Eculizumab) Market Size (2021-2032) & (US$ Million) Figure 48. Taiwan Soliris (Eculizumab) Market Size (2021-2032) & (US$ Million) Figure 49. Southeast Asia Soliris (Eculizumab) Market Size (2021-2032) & (US$ Million) Figure 50. India Soliris (Eculizumab) Market Size (2021-2032) & (US$ Million) Figure 51. Australia Soliris (Eculizumab) Market Size (2021-2032) & (US$ Million) Figure 52. South America, Middle East & Africa Soliris (Eculizumab) Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Soliris (Eculizumab) Market Share by Type (2021-2032) Figure 54. South America, Middle East & Africa Soliris (Eculizumab) Market Share by Application (2021-2032) Figure 55. South America, Middle East & Africa Soliris (Eculizumab) Market Share by Country (2021-2032) Figure 56. Brazil Soliris (Eculizumab) Market Size (2021-2032) & (US$ Million) Figure 57. South Africa Soliris (Eculizumab) Market Size (2021-2032) & (US$ Million) Figure 58. Saudi Arabia Soliris (Eculizumab) Market Size (2021-2032) & (US$ Million) Figure 59. Turkey Soliris (Eculizumab) Market Size (2021-2032) & (US$ Million) Figure 60. Argentina Soliris (Eculizumab) Market Size (2021-2032) & (US$ Million) Figure 61. UAE Soliris (Eculizumab) Market Size (2021-2032) & (US$ Million) Figure 62. Egypt Soliris (Eculizumab) Market Size (2021-2032) & (US$ Million) Figure 63. Chile Soliris (Eculizumab) Market Size (2021-2032) & (US$ Million) Figure 64. Research Process Figure 65. Key Executives Interviewed

Scope & coverage.

Types
  • Plasma Exchange
  • Plasma Infusion
Applications
  • PNH
  • aHUS
  • Others
Companies covered
  • Alexion

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Soliris (Eculizumab) Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Plasma Exchange
  5. 1.2.3 Plasma Infusion
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global Soliris (Eculizumab) Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 PNH
  9. 1.3.3 aHUS
  10. 1.3.4 Others
  11. 1.4 Global Market Growth Prospects
  12. 1.5 Global Soliris (Eculizumab) Growth Trends by Region
  13. 1.5.1 Global Soliris (Eculizumab) Market Size by Region: 2021 VS 2025 VS 2032
  14. 1.5.2 Soliris (Eculizumab) Market Size by Region (2021-2026)
  15. 1.5.3 Soliris (Eculizumab) Market Size by Region (2027-2032)
  16. 1.6 Assumptions and Limitations
  17. 1.7 Study Goals and Objectives
  18. 1.8 Years Considered
2 Global Soliris (Eculizumab) Market Dynamics
  1. 2.1 Soliris (Eculizumab) Industry Trends
  2. 2.2 Soliris (Eculizumab) Industry Drivers
  3. 2.3 Soliris (Eculizumab) Industry Opportunities and Challenges
  4. 2.4 Soliris (Eculizumab) Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Soliris (Eculizumab) Revenue by Company (2021-2026)
  2. 3.2 Global Soliris (Eculizumab) Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Soliris (Eculizumab) Key Company Head office and Area Served
  4. 3.4 Global Soliris (Eculizumab) Company, Product Type & Application
  5. 3.5 Global Soliris (Eculizumab) Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Soliris (Eculizumab) Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Soliris (Eculizumab) Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Soliris (Eculizumab) Tier 1, Tier 2, and Tier 3
4 Soliris (Eculizumab) Market by Type
  1. 4.1 Global Soliris (Eculizumab) Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Soliris (Eculizumab) Market Size by Type (2021-2032)
  3. 4.3 Global Soliris (Eculizumab) Market Size Share by Type (2021-2032)
5 Soliris (Eculizumab) Market by Application
  1. 5.1 Global Soliris (Eculizumab) Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Soliris (Eculizumab) Market Size by Application (2021-2032)
  3. 5.3 Global Soliris (Eculizumab) Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Alexion
  2. 6.1.1 Alexion Company Information
  3. 6.1.2 Alexion Business Overview
  4. 6.1.3 Alexion Soliris (Eculizumab) Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Alexion Soliris (Eculizumab) Product Portfolio
  6. 6.1.5 Alexion Recent Developments
7 North America
  1. 7.1 North America Soliris (Eculizumab) Market Size (2021-2032)
  2. 7.2 North America Soliris (Eculizumab) Market Size by Type
  3. 7.2.1 North America Soliris (Eculizumab) Market Size by Type (2021-2026)
  4. 7.2.2 North America Soliris (Eculizumab) Market Size by Type (2027-2032)
  5. 7.2.3 North America Soliris (Eculizumab) Market Share by Type (2021-2032)
  6. 7.3 North America Soliris (Eculizumab) Market Size by Application
  7. 7.3.1 North America Soliris (Eculizumab) Market Size by Application (2021-2026)
  8. 7.3.2 North America Soliris (Eculizumab) Market Size by Application (2027-2032)
  9. 7.3.3 North America Soliris (Eculizumab) Market Share by Application (2021-2032)
  10. 7.4 North America Soliris (Eculizumab) Market Size by Country
  11. 7.4.1 North America Soliris (Eculizumab) Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Soliris (Eculizumab) Market Size by Country (2021-2026)
  13. 7.4.3 North America Soliris (Eculizumab) Market Size by Country (2027-2032)
  14. 7.4.4 North America Soliris (Eculizumab) Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Soliris (Eculizumab) Market Size (2021-2032)
  2. 8.2 Europe Soliris (Eculizumab) Market Size by Type
  3. 8.2.1 Europe Soliris (Eculizumab) Market Size by Type (2021-2026)
  4. 8.2.2 Europe Soliris (Eculizumab) Market Size by Type (2027-2032)
  5. 8.2.3 Europe Soliris (Eculizumab) Market Share by Type (2021-2032)
  6. 8.3 Europe Soliris (Eculizumab) Market Size by Application
  7. 8.3.1 Europe Soliris (Eculizumab) Market Size by Application (2021-2026)
  8. 8.3.2 Europe Soliris (Eculizumab) Market Size by Application (2027-2032)
  9. 8.3.3 Europe Soliris (Eculizumab) Market Share by Application (2021-2032)
  10. 8.4 Europe Soliris (Eculizumab) Market Size by Country
  11. 8.4.1 Europe Soliris (Eculizumab) Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Soliris (Eculizumab) Market Size by Country (2021-2026)
  13. 8.4.3 Europe Soliris (Eculizumab) Market Size by Country (2027-2032)
  14. 8.4.4 Europe Soliris (Eculizumab) Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Soliris (Eculizumab) Market Size (2021-2032)
  2. 9.2 China Soliris (Eculizumab) Market Size by Type
  3. 9.2.1 China Soliris (Eculizumab) Market Size by Type (2021-2026)
  4. 9.2.2 China Soliris (Eculizumab) Market Size by Type (2027-2032)
  5. 9.2.3 China Soliris (Eculizumab) Market Share by Type (2021-2032)
  6. 9.3 China Soliris (Eculizumab) Market Size by Application
  7. 9.3.1 China Soliris (Eculizumab) Market Size by Application (2021-2026)
  8. 9.3.2 China Soliris (Eculizumab) Market Size by Application (2027-2032)
  9. 9.3.3 China Soliris (Eculizumab) Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Soliris (Eculizumab) Market Size (2021-2032)
  2. 10.2 Asia Soliris (Eculizumab) Market Size by Type
  3. 10.2.1 Asia Soliris (Eculizumab) Market Size by Type (2021-2026)
  4. 10.2.2 Asia Soliris (Eculizumab) Market Size by Type (2027-2032)
  5. 10.2.3 Asia Soliris (Eculizumab) Market Share by Type (2021-2032)
  6. 10.3 Asia Soliris (Eculizumab) Market Size by Application
  7. 10.3.1 Asia Soliris (Eculizumab) Market Size by Application (2021-2026)
  8. 10.3.2 Asia Soliris (Eculizumab) Market Size by Application (2027-2032)
  9. 10.3.3 Asia Soliris (Eculizumab) Market Share by Application (2021-2032)
  10. 10.4 Asia Soliris (Eculizumab) Market Size by Country
  11. 10.4.1 Asia Soliris (Eculizumab) Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Soliris (Eculizumab) Market Size by Country (2021-2026)
  13. 10.4.3 Asia Soliris (Eculizumab) Market Size by Country (2027-2032)
  14. 10.4.4 Asia Soliris (Eculizumab) Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Soliris (Eculizumab) Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Soliris (Eculizumab) Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Soliris (Eculizumab) Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Soliris (Eculizumab) Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Soliris (Eculizumab) Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Soliris (Eculizumab) Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Soliris (Eculizumab) Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Soliris (Eculizumab) Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Soliris (Eculizumab) Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Soliris (Eculizumab) Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Soliris (Eculizumab) Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Soliris (Eculizumab) Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Soliris (Eculizumab) Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Soliris (Eculizumab) Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst